No evidence of a synergistic effect of HIV infection and diabetes mellitus type 2 on fat distribution, plasma adiponectin or inflammatory markers.
Malene Hove-SkovsgaardJulie AbildgaardMarco GelpiJulie Christine GaardboLilian KolteHenrik UllumMarius TrøseidBirgitte LindegaardSusanne Dam NielsenPublished in: BMC infectious diseases (2020)
A synergistic effect of HIV and DM2 was not found for any of the outcomes. However, HIV + DM2+ had features related to both HIV infection and DM2 with a high trunk/limb ratio, high trunk fat mass, low concentration of plasma adiponectin and elevated concentrations of IL-6 and sCD14. This could contribute to elevated risk of CVD.